Paid Clinical Trials Sioux Falls
Discover 206 paid clinical trials in Sioux Falls, South Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06205485
Conditions
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Leucovorin
Oxaliplatin
Fluoruracil
Capecitabine
Radiation
ELANA 841PAT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal
Sponsor:
Carl Zeiss Meditec, Inc.
Location:
Code:
NCT06264232
Conditions
Cataract Senile
Eligibility Criteria
Sex: All
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
Cataract Surgery
Observational StudyMOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.
Sponsor:
Carolyn M Hettrich
Location:
Code:
NCT02075775
Conditions
Other Instability, Shoulder
Dislocations
Subluxations
Recurrent Dislocation of Shoulder Region
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Dipraglurant with LevodopaDipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Sponsor:
Addex Pharma S.A.
Location:
Code:
NCT04857359
Conditions
Parkinson Disease
Dyskinesia, Drug-Induced
Dyskinesias
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Dipraglurant
Placebo
enVista® BeyondStudy to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
Sponsor:
Bausch & Lomb Incorporated
Location:
Code:
NCT06333015
Conditions
Cataract
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
enVista EY Beyond IOL
enVista MX60E monofocal IOL
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pembrolizumab & Sacituzumab TirxumotecanA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312137
Conditions
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Cisplatin
Pemetrexed
Gemcitabine
Novel Sling vs. Traditional SlingComparison Of A Novel Sling With A Traditional Abduction Sling After Shoulder Surgery
Sponsor:
Orthopedic Institute, Sioux Falls, SD
Location:
Code:
NCT05274737
Conditions
Rotator Cuff Tears
Osteo Arthritis Shoulders
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Novel sling
Traditional abduction sling
Kamuvudine-8Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy
Sponsor:
University of Kentucky
Location:
Code:
NCT06164587
Conditions
Geographic Atrophy
Age-Related Macular Degeneration
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
K8
PembrolizumabKEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT04165070
Conditions
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Carboplatin
Paclitaxel
Pemetrexed
Vibostolimab
AMG 509Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Amgen
Location:
Code:
NCT04221542
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AMG 509
Abiraterone
Enzalutamide